CLINICAL CHARACTERISTICS OF LOW GRADE GLIOMA PATIENTS WITH NON-CANONICAL IDH1 AND IDH2 MUTATIONS
Publication
, Conference
Peters, K; Lipp, E; Broadwater, G; Herndon, JII; Johnson, M; Randazzo, D; Desjardins, A; Friedman, H; Ashley, D; Affronti, M
Published in: NEURO-ONCOLOGY
2020
Duke Scholars
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
2020
Volume
22
Start / End Page
137 / 137
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Peters, K., Lipp, E., Broadwater, G., Herndon, J. I. I., Johnson, M., Randazzo, D., … Affronti, M. (2020). CLINICAL CHARACTERISTICS OF LOW GRADE GLIOMA PATIENTS WITH NON-CANONICAL IDH1 AND IDH2 MUTATIONS. In NEURO-ONCOLOGY (Vol. 22, pp. 137–137).
Peters, Katherine, Eric Lipp, Gloria Broadwater, James I. I. Herndon, Margaret Johnson, Dina Randazzo, Annick Desjardins, Henry Friedman, David Ashley, and Mary Affronti. “CLINICAL CHARACTERISTICS OF LOW GRADE GLIOMA PATIENTS WITH NON-CANONICAL IDH1 AND IDH2 MUTATIONS.” In NEURO-ONCOLOGY, 22:137–137, 2020.
Peters K, Lipp E, Broadwater G, Herndon JII, Johnson M, Randazzo D, et al. CLINICAL CHARACTERISTICS OF LOW GRADE GLIOMA PATIENTS WITH NON-CANONICAL IDH1 AND IDH2 MUTATIONS. In: NEURO-ONCOLOGY. 2020. p. 137–137.
Peters, Katherine, et al. “CLINICAL CHARACTERISTICS OF LOW GRADE GLIOMA PATIENTS WITH NON-CANONICAL IDH1 AND IDH2 MUTATIONS.” NEURO-ONCOLOGY, vol. 22, 2020, pp. 137–137.
Peters K, Lipp E, Broadwater G, Herndon JII, Johnson M, Randazzo D, Desjardins A, Friedman H, Ashley D, Affronti M. CLINICAL CHARACTERISTICS OF LOW GRADE GLIOMA PATIENTS WITH NON-CANONICAL IDH1 AND IDH2 MUTATIONS. NEURO-ONCOLOGY. 2020. p. 137–137.
Published In
NEURO-ONCOLOGY
EISSN
1523-5866
ISSN
1522-8517
Publication Date
2020
Volume
22
Start / End Page
137 / 137
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1109 Neurosciences